Yacca Pharmaceuticals

Roorkee, India
Produces high-quality pharmaceutical products such as tablets, capsules, syrup, and ointments.

About Yacca Pharmaceuticals

Yacca Pharmaceuticals is a Healthcare company based in Roorkee (India). It produces high-quality pharmaceutical products such as tablets, capsules, syrup, and ointments. It operates on a B2B model. The company has 31 employees. Its Indian entity Yacca Pharmaceuticals Private Limited reported revenue of β‚Ή40.38 Cr. Its focus areas include Healthcare and Pharmaceuticals, Pharmaceuticals, Manufacturing and Drug Production. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Yacca Pharmaceuticals operates with a B2B model, focusing on healthcare and pharmaceuticals, producing pharmaceutical products, producing manufactured goods, and drug production. Produces high-quality pharmaceutical products such as tablets, capsules, syrup, and ointments. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Key Metrics
  • Annual Revenue
    ₹40.38 Cr

    FY 2024 · +6% YoY

  • Net Profit
    ₹70.4 Lakh

    FY 2024 · 2% margin

  • EBITDA
    ₹2.98 Cr

    FY 2024 · 7% margin

  • Employee Count
    31

Board of directors of Yacca Pharmaceuticals Private Limited (Yacca Pharmaceuticals)

Yacca Pharmaceuticals Private Limited is the primary company behind Yacca Pharmaceuticals. The board of Yacca Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Pankaj Kumar Bansal, appointed in 1989.

DirectorDesignationAppointedTenureEntity
Pankaj Kumar Bansal
DIN 01185362
Managing Director11 Dec 198936 yrs 10 moYacca Pharmaceuticals Private Limited
Anjali Bansal
DIN 01185344
Director11 Dec 198936 yrs 10 moYacca Pharmaceuticals Private Limited
Prateek Mohan Bansal
DIN 08195411
Director11 Aug 20188 yrs 2 moYacca Pharmaceuticals Private Limited
Aayush Mohan Bansal
DIN 08195424
Director11 Aug 20188 yrs 2 moYacca Pharmaceuticals Private Limited

Financials of Yacca Pharmaceuticals

Figures of Yacca Pharmaceuticals Private Limited, the primary company behind Yacca Pharmaceuticals, for FY 2024. Revenue was ₹40.38 Cr (+6% year on year). Net profit was ₹70.4 Lakh (2% margin). EBITDA was ₹2.98 Cr (7% margin). Revenue has grown at a compounded annual rate of +32% over three years and +33% over five years.

  • ₹40.38 CrRevenue · FY 2024 · +6% YoY
  • ₹70.4 LakhNet profit · 2% margin
  • ₹2.98 CrEBITDA · 7% margin
  • ₹10 LakhPaid-up capital
  • 31Employees (provident fund records)
  • +32%Revenue CAGR, 3 years
  • +33%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Yacca Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Yacca Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Yacca Pharmaceuticals

Yacca Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Yacca Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Yacca Pharmaceuticals

Yacca Pharmaceuticals is headquartered in Roorkee, India. It is registered at Roorkee, Uttarakhand, India.

Yacca Pharmaceuticals has 31 employees.

The primary company behind Yacca Pharmaceuticals, Yacca Pharmaceuticals Private Limited, reported revenue of β‚Ή40.38 Cr for FY 2024, up 6% year on year.

Yacca Pharmaceuticals operates with a B2B model, focusing on healthcare and pharmaceuticals, producing pharmaceutical products, producing manufactured goods, and drug production. Produces high-quality pharmaceutical products such as tablets, capsules, syrup, and ointments. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Yacca Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Yacca Pharmaceuticals operates through Yacca Pharmaceuticals Private Limited.

The legal entities of Yacca Pharmaceuticals currently have 4 directors, including Prateek Mohan Bansal, Aayush Mohan Bansal, Pankaj Kumar Bansal and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available